Jove
Visualize
Contact Us

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Generation of Clinical Epigenetics Analysis and Diagnosis for Precision Medicine.

Diagnostics (Basel, Switzerland)·2025
Same author

The histone deacetylase inhibitor CT-101 flips the switch to fetal hemoglobin expression in sickle cell disease mice.

PloS one·2025
Same author

Cholesterol-conjugated miR-29b induces fetal haemoglobin expression via γ-globin promoter demethylation in the Townes mouse model for sickle cell anaemia.

British journal of haematology·2025
Same author

Biomarkers Analysis for Heterogeneous Immune Responses of Quiescent CD8+cells -A Clue for Personalized Immunotherapy.

Biomarkers journal·2023
Same author

Breakthroughs of 2015-Personalized Immunotherapy Based on Individual GWAS and Biomarkers.

Biomarkers journal·2023
Same author

Clinical Genomic Analysis and Diagnosis --Genomic Analysis <i>Ex Vivo</i>, <i>in Vitro</i> and <i>in Silico</i>.

Clinical medicine and diagnostics·2023
Same journal

Extreme Few-View Tomography without Training Data.

Biomedical journal of scientific & technical research·2024
Same journal

Morphing from the TV-Norm to the <i>l</i> <sub></sub> -Norm.

Biomedical journal of scientific & technical research·2024
Same journal

An Integrative Genomics Approach for Associating Genetic Susceptibility with the Tumor Immune Microenvironment in Triple Negative Breast Cancer.

Biomedical journal of scientific & technical research·2024
Same journal

Closing the Gaps on Medical Education in Low-Income Countries Through Information & Communication Technologies: The Mozambique Experience.

Biomedical journal of scientific & technical research·2023
Same journal

Immunomodulatory Strategies for Spinal Cord Injury.

Biomedical journal of scientific & technical research·2023
Same journal

Estrogen Sulfotransferase Induction Inhibits Breast Cancer Cell Line MCF-7 Proliferation.

Biomedical journal of scientific & technical research·2022
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 14, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K

Machine-learning Modeling for Personalized Immunotherapy- An Evaluation Module.

Xiaonan Ying1, Biaoru Li2

  • 1University of Nebraska Medical Center, Omaha, NE 68131, USA.

Biomedical Journal of Scientific & Technical Research
|October 11, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces a new machine-learning model to personalize cancer immunotherapy. By analyzing single-cell genomics, it predicts optimal immune-cell therapies and targeted drugs for improved patient outcomes.

Keywords:
Gene ExpressionMachine-LearningPathway AnalysisPersonalized ImmunotherapySingle-Cell Genomic AnalysisTargeting TherapyTumor-Infiltrating Lymphocytes

More Related Videos

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.4K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.1K

Related Experiment Videos

Last Updated: Jul 14, 2025

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.0K
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.4K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.1K

Area of Science:

  • Oncology
  • Immunology
  • Computational Biology

Background:

  • Current immune-cell and targeted therapies for cancer face challenges in safety (cytokine releasing syndrome), specificity (off-targeting), and cost.
  • Personalized immunotherapy strategies are emerging to address these limitations in cancer treatment.

Purpose of the Study:

  • To develop a novel immunotherapy module utilizing machine learning and single-cell genomics.
  • To predict optimal immune-cell therapies and targeted drugs for individual cancer patients.

Main Methods:

  • Discovery of quiescent genes in tumor-infiltrating immune cells.
  • Single-cell genomics analysis to study heterogeneous immune responses against neoantigens.
  • Development of a machine-learning model to assess optimal immunotherapy strategies.

Main Results:

  • The machine-learning model, integrated with single-cell genomic data, can predict optimal treatments.
  • Identification of potential personalized immune-cell (e.g., T-cells) and targeted drug (e.g., PD1, CTLA4 inhibitors) combinations.

Conclusions:

  • This new generation of immunotherapy module offers a predictive approach for personalized cancer treatment.
  • The integration of machine learning and single-cell genomics holds promise for overcoming current immunotherapy challenges.